![SPECT-CT in routine clinical use: Increment in patient radiation dose compared to SPECT alone | Journal of Nuclear Medicine SPECT-CT in routine clinical use: Increment in patient radiation dose compared to SPECT alone | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/53/supplement_1/477/F1.large.jpg)
SPECT-CT in routine clinical use: Increment in patient radiation dose compared to SPECT alone | Journal of Nuclear Medicine
![Radionuclide bone scan SPECT-CT: lowering the dose of CT significantly reduces radiation dose without impacting CT image quality. | Semantic Scholar Radionuclide bone scan SPECT-CT: lowering the dose of CT significantly reduces radiation dose without impacting CT image quality. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f0718489843e21442fc8c6de33bc75fa10ee7d67/2-Table1-1.png)
Radionuclide bone scan SPECT-CT: lowering the dose of CT significantly reduces radiation dose without impacting CT image quality. | Semantic Scholar
![Current Status of Patient Radiation Exposure of Cardiac Positron Emission Tomography and Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging | Circulation: Cardiovascular Imaging Current Status of Patient Radiation Exposure of Cardiac Positron Emission Tomography and Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging | Circulation: Cardiovascular Imaging](https://www.ahajournals.org/cms/asset/7b3e18ac-cc94-4de7-b9e1-8c1f007e3d43/e007565fig04.gif)
Current Status of Patient Radiation Exposure of Cardiac Positron Emission Tomography and Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging | Circulation: Cardiovascular Imaging
![Cancers | Free Full-Text | Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels Cancers | Free Full-Text | Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels](https://www.mdpi.com/cancers/cancers-13-02828/article_deploy/html/images/cancers-13-02828-g001.png)